Print Page

给 医 护 专 业 人 员 的 信
 
FDA warns of rare but serious drug reaction to the antiseizure medicines levetiracetam (Keppra, Keppra XR, Elepsia XR, Spritam) and clobazam (Onfi, Sympazan) (Letter to Healthcare Professionals) (English only)
 
 
 
附件:
  1. Sympazan (English only)  
Related Information:
The United States: FDA warns of rare but serious drug reaction to the antiseizur... 上载于 2023-11-29
Clobazam-containing products: Assessing the Potential Risk of Drug Reaction with... 上载于 2020-12-10
Canada: Summary Safety Review: Clobazam-containing products: Assessing the poten... 上载于 2020-12-10
 
back